Finance

Beta
Lists
SRZN:NASDAQ
Surrozen Inc
USD 21,12
+1,78%
(+0,37) 1D
17 Jul., 15:18:15 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRZN...
Open
USD 20,51
High
USD 21,83
Low
USD 19,98
Mkt. cap
245,21 m
Avg. vol.
164,85 k
Volume
97,46 k
52-wk high
USD 35,00
52-wk low
USD 8,21
EPS
-USD 35,44
Beta
0,51
Shares outstanding
11,61 m
No. of employees
44
Open
USD 20,51
High
USD 21,83
Low
USD 19,98
Mkt. cap
245,21 m
Avg. vol.
164,85 k
Volume
97,46 k
52-wk high
USD 35,00
52-wk low
USD 8,21
EPS
-USD 35,44
Beta
0,51
Shares outstanding
11,61 m
No. of employees
44
News stories
From sources across the web
About Surrozen Inc
CEO-
Employees44
Founded2015
HeadquartersSouth San Francisco, Kalifornië, Verenigde State van Amerika
Sector-
Websitesurrozen.com
Analyst ratings
Based on 4 analysts giving stock ratings to SRZN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for SRZN in the last 3 months.
Highest
Current USD 21,12
USD 44,00 (+108,33%)
Average
USD 43,33 (+105,16%)
Lowest
USD 42,00 (+98,86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Maintained
USD 44,00
+108,3%
05/26/2026
Patrick Dolezal
LifeSci Capital
Buy
Reiterated
USD 44,00
+108,3%
05/09/2026
Unknown Analyst
Guggenheim
Buy
Maintained
USD 42,00
+98,9%
05/06/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/07/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
USD 40,00
+89,4%
03/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
983,00 k
983,00 k
528,00 k
5,00 m
Cost of goods sold
6,04 m
7,77 m
8,99 m
9,33 m
Cost of revenue
6,04 m
7,77 m
8,99 m
9,33 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,96 m
4,09 m
4,18 m
6,13 m
Operating expense
3,96 m
4,09 m
4,18 m
6,13 m
Total operating expenses
10,00 m
11,87 m
13,17 m
15,46 m
Operating income
-9,02 m
-10,88 m
-12,64 m
-10,46 m
Other non operating income
47,74 m
-61,67 m
-171,31 m
-117,96 m
EBT including unusual items
39,75 m
-71,64 m
-183,16 m
-127,50 m
EBT excluding unusual items
39,75 m
-71,64 m
-183,16 m
-127,50 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
39,75 m
-71,64 m
-183,16 m
-127,50 m
Net profit margin
4 043,34%
-7 288,20%
-34 689,20%
-2 550,10%
Earnings per share
-1,14
-3,60
-9,62
-4,63
Interest and investment income
1,02 m
911,00 k
788,00 k
912,00 k
Interest expense
-
-
-
-
Net interest expenses
1,02 m
911,00 k
788,00 k
912,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,88 m
-10,82 m
-12,59 m
-10,39 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer